XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

18. SHARE-BASED COMPENSATION

 

The Company accounts for share-based compensation in accordance with ASC 718, Compensation – Stock Compensation. ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee is required to provide service in exchange for the award, usually the vesting period.

 

Share-based compensation for employees and non-employees is recorded in the Consolidated Statement of Operations as a component of general and administrative expense with a corresponding increase to additional paid-in capital in shareholders' equity.

 

Stock Options

 

On March 20, 2019, the Company granted options outside of any equity plan to two employees and one non-employee for the purchase of an aggregate of 180,000 shares of the Company's common stock. All the options have an exercise price of $1.06 per share and expire on March 20, 2023. Under the Black-Scholes option pricing model, the fair value of the 180,000 options on the date of grant was estimated at $123,130.

 

No options were granted during the three months ended March 31, 2020.

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during the period January 10, 2019 (inception) to March 31, 2019:

 

      2019  
Expected dividend yield             0%  
Expected volatility         90%  
Risk-free interest rate         2.40-2.47%  
Expected life of options         4.0 years  

   

The following table represents stock option activity for the three months ended March 31, 2020 and the period January 10, 2019 (Inception) to March 31, 2019:

 

   Number of
Options
   Weighted-
Average
Exercise
Price per
Share
   Weighted-
Average
Contractual
Life in
Years
   Aggregate
Intrinsic
Value
 
Outstanding – December 31, 2019   8,695,000   $0.63    1.34   $2,264,760 
Granted   

    

    

    

 
Exercised   

        

    

 
Cancelled or Expired   (3,630,000)   0.61    

    

 
Outstanding – March 31, 2020   5,065,000   $0.65    1.94   $3,183,450 
Exercisable – March 31, 2020   5,065,000   $0.65    1.94   $3,183,450 

 

   Number of
Options
   Weighted-
Average
Exercise
Price per
Share
   Weighted-
Average
Contractual
Life in
Years
   Aggregate
Intrinsic
Value
 
Outstanding – January 10, 2019   13,990,000   $0.61    3.15   $ 
Granted   180,000    1.06         
Exercised   

             
Cancelled or Expired                
Outstanding – March 31, 2019   14,170,000   $0.61    1.82   $6,359,500 
Exercisable – March 31, 2019   13,710,000   $0.60    1.81   $6,345,500 

 

For the three months ended March 31, 2020, there were no unvested stock options.

 

The Company did not record any share-based compensation expense for the three months ended March 31, 2020. Compensation expense related to stock options is recorded in share-based compensation expense in the Consolidated Statement of Operations. For the three months ended March 31, 2020 and the period January 10, 2019 (Inception) to March 31, 2019, there were no unrecognized compensation expense related to stock options.

 

Restricted Stock Awards

 

On March 25, 2019, ComSovereign's Board of Directors granted an aggregate of 80,000 restricted stock awards ("RSAs") to a non-employee for consulting services, of which 60,000 RSAs immediately vested and 20,000 RSAs vested upon the change in control of ComSovereign in connection with the ComSovereign Acquisition. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $352,000. ComSovereign recognized the full $352,000 of stock compensation expense for the RSAs during the period January 10, 2019 (inception) to March 31, 2019.

 

For the three months ended March 31, 2020, the Company did not recognize any expense related to RSAs. For the period January 10, 2019 (Inception) through March 31, 2019, the Company  recognized $72,500  compensation expense related to RSAs. See Note 1 – Description of Business and Basis of Presentation for information about the shares issued in connection with the formation of ComSovereign.

 

See Note 23 – Subsequent Events for information related to the adoption of the 2020 Long-Term Incentive Plan.